HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epithelial to Mesenchymal Transition(EMT) Regulated by MicroRNA-429 in Pancreatic Ductal Adenocarcinoma (PDAC).

Abstract
In this study, we aimed to investigate the role of miRNA-429 in the pathogenesis of pancreatic ductal adenocarcinoma(PDAC) and the potential mechanism of this procedure. Totally 95 consecutive patients with PDAC diagnosed by pathology were retrospectively collected from June 1st , 2015 to August 30th, 2019 in Department of General Surgery, Jingmen First People's Hospital. The human pancreatic cancer cell line Bxpc-3 and Panc-1 were used and the cell proliferation and migration were detected by MTT assays and Transwell assays, respectively. The quantitative real-time polymerase chain reaction (qRT-PCR) was applied to evaluate the expression in RNA level. Our results showed that overexpression of miRNA-429 could suppress the cell invasion, proliferation and metastasis through regulating the process of EMT in PDAC cell line, while low expression of miRNA-429 had the opposite effects. We demonstrated that miRNA-429 had critical roles in the pathogenesis of PDAC. Clinically, we observed that tumor tissues from patients with PDAC exhibited significantly decreasing in miRNA-429 expression compared with the non-tumor tissues. Additionally, decreased expression of miRNA-429 in tumor tissues of patients with PDAC was associated with poorer prognosis and several clinical-pathological characteristics. In conclusion, miRNA-429 exerted anti-tumor functions in PDAC through the regulation of EMT process. The results of this study would provide a novel insight into tumorigenesis and the basis for the development of miRNA-targeting therapies against PDAC.
AuthorsGang Zheng, Zhigang Wang, Jie Tang, Yin Sun, Zhou Hu, Huiping Chen
JournalBioscience reports (Biosci Rep) (Jan 18 2021) ISSN: 1573-4935 [Electronic] England
PMID33458739 (Publication Type: Journal Article)
CopyrightCopyright 2021 The Author(s).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: